These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2444302)
1. The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine. Dawes PT; Jackson R; Shadforth MF; Lewin IV; Stanworth DR Br J Rheumatol; 1987 Oct; 26(5):351-3. PubMed ID: 2444302 [TBL] [Abstract][Full Text] [Related]
2. D-penicillamine treatment in rheumatoid arthritis monitored by plasma alfa-1-antitrypsin-IgA complexes and plasma and urinary sulphur containing aminoacids. Wollheim FA; Jeppsson JO; Laurell CB Scand J Rheumatol Suppl; 1979; (28):21-7. PubMed ID: 313074 [TBL] [Abstract][Full Text] [Related]
3. Circulating protein complexes in D-penicillamine therapy of rheumatoid arthritis. Correlation between IgG- and alpha 1-antitrypsin-IgA complexes and clinical response. Norberg R; Wollheim FA; Gedda PO Acta Med Scand; 1980; 208(5):393-6. PubMed ID: 6969974 [TBL] [Abstract][Full Text] [Related]
4. Microheterogeneity of alpha 1-antitrypsin in relation to the concentration of its complex with immunoglobulin A in the sera of patients with rheumatoid arthritis. Hrycaj P; Nayyar S; Stanworth DR; Müller W Clin Exp Rheumatol; 1996; 14(2):119-23. PubMed ID: 8737716 [TBL] [Abstract][Full Text] [Related]
5. Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. Walters MT; Stevenson FK; Goswami R; Smith JL; Cawley MI Ann Rheum Dis; 1989 Nov; 48(11):905-11. PubMed ID: 2512862 [TBL] [Abstract][Full Text] [Related]
6. Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se. Scott LJ; Evans EL; Dawes PT; Russell GI; Mattey DL Br J Rheumatol; 1998 Apr; 37(4):398-404. PubMed ID: 9619890 [TBL] [Abstract][Full Text] [Related]
7. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine. Haataja M; Nissilä M; Ruutsalo HM Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378 [TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs. Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902 [TBL] [Abstract][Full Text] [Related]
9. Comparison of penicillamine and gold treatment in early rheumatoid arthritis. Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190 [TBL] [Abstract][Full Text] [Related]
10. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis. Aylward M; Maddock J; Wheeldon R; Parker RJ Rheumatol Rehabil; 1975 May; 14(2):101-14. PubMed ID: 238274 [TBL] [Abstract][Full Text] [Related]
11. Drug-induced IgA deficiency in rheumatoid arthritis. Stanworth DR; Williamson JP; Shadforth M; Felix-Davies D; Thompson R Lancet; 1977 May; 1(8019):1001-2. PubMed ID: 67433 [No Abstract] [Full Text] [Related]
12. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine. Palosuo T; Kajander A; von Essen R; Milgrom F Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039 [No Abstract] [Full Text] [Related]
13. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis. Sanders KM; Hertzman A; Escobar MR; Littman BH Ann Rheum Dis; 1987 Apr; 46(4):273-6. PubMed ID: 3592781 [TBL] [Abstract][Full Text] [Related]
14. Decreased pokeweed mitogen-induced IgM and IgM rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine. Olsen NJ; Jasin HE Arthritis Rheum; 1984 Sep; 27(9):985-94. PubMed ID: 6433938 [TBL] [Abstract][Full Text] [Related]
15. Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis. Pritchard MH; Nuki G Ann Rheum Dis; 1978 Dec; 37(6):493-503. PubMed ID: 107867 [TBL] [Abstract][Full Text] [Related]
16. Relationship between severity of rheumatoid arthritis and serum alpha 1-antitrypsin. Abboud RT; Chalmers A; Gofton JP; Richter AM; Enarson DA J Rheumatol; 1991 Oct; 18(10):1490-5. PubMed ID: 1765973 [TBL] [Abstract][Full Text] [Related]
17. Do penicillamine and Myocrisin act the same way in rheumatoid arthritis? Munthe E; Jellum E; Aaseth J Rheumatol Rehabil; 1978; Suppl():105-8. PubMed ID: 103179 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485 [TBL] [Abstract][Full Text] [Related]
19. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269 [TBL] [Abstract][Full Text] [Related]
20. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis. Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]